Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Antibody >  ANTI-SENP1

ANTI-SENP1

Basic information Safety Supplier Related

ANTI-SENP1 Basic information

Product Name:
ANTI-SENP1
Synonyms:
  • Anti-SENP1 antibody produced in rabbit
  • Anti-Sentrin/SUMO-specific protease SENP1 antibody produced in rabbit
  • Anti-Sentrin-specific protease 1 antibody produced in rabbit
  • ANTI-SENP1
  • ANTI-SENTRIN-SPECIFIC PROTEASES 1
  • RABBIT ANTI-HUMAN SENP1
  • RABBIT ANTI-HUMAN SENTRIN/SUMO-SPECIFIC PROTEASE 1
  • Anti-SuPr-2
MW:
0
Mol File:
Mol File
More
Less

ANTI-SENP1 Chemical Properties

storage temp. 
-20°C
form 
buffered aqueous solution
biological source
rabbit
More
Less

Safety Information

WGK Germany 
nwg
Storage Class
10 - Combustible liquids
More
Less

ANTI-SENP1 Usage And Synthesis

Uses

Anti-SENP1 antibody produced in rabbit, a Prestige Antibody, is developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org). Each antibody is tested by immunohistochemistry against hundreds of normal and disease tissues. These images can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. The antibodies are also tested using immunofluorescence and western blotting. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit .

Biochem/physiol Actions

SENP1 (SUMO1/sentrin specific peptidase 1) is a sentrin/SUMO-specific protease (SENPs) belonging to the de-SUMOylation protease family. It essentially regulates the androgen receptor-dependent transcription and hypoxia signaling. It exerts pro-oncogenic characteristics in various types of malignancies. Studies show that SENP1 is overexpressed in both the cancers, precancerous prostate intraepithelial neoplasia (PIN) lesions and prostate cancer tissues; however, it is correlated with the intensity and recurrence of prostate cancer. SENP1 regulates the expression of two critical bone remodeling proteins, matrix metalloproteinase 2 (MMP2) and MMP9 via HIF1a signaling pathway. Research shows the correlation between SENP1 and the metastasis in prostate cancer, since; it has identifying property as a prognostic marker.

ANTI-SENP1Supplier

Sigma-Aldrich
Tel
021-61415566 800-8193336
Email
orderCN@merckgroup.com
Shanghai guandao biology engineering co., ltd
Tel
18818239863
Email
3171921642@qq.com
Atlas antibodies
Tel
46-854595850
Email
order@atlasantibodies.com
Merck KGaA
Tel
21-20338288
Email
ordercn@merckgroup.com